Frontlight ResearchEarly access
CompletedNo phase
Development and Validation of an Interpretable Machine Learning Model for Predicting Venous Thromboembolism(VTE)in Intensive Care Unit (ICU) Patients
Key facts
- Who runs it
- Beijing Tsinghua Chang Gung Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 12,061 people enrolled
- Started
- 1 Jan 2022
- Ended
- 31 Dec 2025
- Type of study
- Observational
- Record updated
- 19 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- age ≥18 years
- ICU length of stay ≥48 hour
- the first ICU admission
Who cannot take part
- VTE diagnosed prior to ICU admission
- VTE diagnosed within 24 hours of ICU admission
- >20% missing values in key variables
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Venous thromboembolism remains a leading cause of preventable mortality in intensive care unit (ICU) patients. Existing risk-stratification tools were developed in general medical populations and lack ICU-specific predictors. This study was to develop and validate an interpretable machine learning (ML) model to predict VTE in ICU patients.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 19 May 2026